177 related articles for article (PubMed ID: 29182795)
1. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
[TBL] [Abstract][Full Text] [Related]
2. Epidermolysis Bullosa: Two rare case reports of COL7A1 and EBS-GEN SEV KRT14 variants with review of literature.
Ali FM; Zhou J; Wang M; Wang Q; Sun L; Mshenga MM; Lu H
BMC Pediatr; 2024 Apr; 24(1):242. PubMed ID: 38580989
[TBL] [Abstract][Full Text] [Related]
3. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Santucci C; Alexandru M; Chen X; Mellerio JE; Karagiannis SN; Jacków-Malinowska J
Hum Immunol; 2024 May; 85(3):110805. PubMed ID: 38703415
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII.
Csorba K; Sesarman A; Oswald E; Feldrihan V; Fritsch A; Hashimoto T; Sitaru C
Cell Mol Life Sci; 2010 Apr; 67(8):1343-51. PubMed ID: 20084423
[TBL] [Abstract][Full Text] [Related]
5. Creation and characterization of novel rat model for recessive dystrophic epidermolysis bullosa: Frameshift mutation of the Col7a1 gene leads to severe blistered phenotype.
Stone W; Strege C; Miller W; Geurts AM; Grzybowski M; Riddle M; Lees C; Eide C; Keene DR; Tufa SF; Seelig D; McGrath J; Tolar J
PLoS One; 2024; 19(5):e0302991. PubMed ID: 38722855
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita.
Gross N; Marketon J; Mousavi S; Kalies K; Ludwig RJ; Bieber K
Front Immunol; 2024; 15():1343299. PubMed ID: 38799441
[TBL] [Abstract][Full Text] [Related]
7. A
Garcia TM; Kiener S; Jagannathan V; Russell DS; Leeb T
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33291836
[TBL] [Abstract][Full Text] [Related]
8. Current Treatment Landscape for Dystrophic Epidermolysis Bullosa: From Surgical Management to Emerging Gene Therapies and Novel Skin Grafts.
Villavisanis DF; Perrault DP; Kiani SN; Cholok D; Fox PM
J Hand Surg Am; 2024 May; 49(5):472-480. PubMed ID: 38085193
[TBL] [Abstract][Full Text] [Related]
9. Advantages of whole-exome sequencing over immunomapping in 67 Brazilian patients with epidermolysis bullosa.
Kelmann SV; Stephan BO; Barbosa SMM; Polastrini RTV; Oliveira ZNP; Rivitti-Machado MC; Spolador GM; Honjo RS; Saida K; Matsumoto N; Kim CA
An Bras Dermatol; 2024; 99(3):350-356. PubMed ID: 38368142
[TBL] [Abstract][Full Text] [Related]
10. A case of dystrophic epidermolysis bullosa with a rare COL7A1 variant.
Amoedo P; Grangeia A; Peralta L; Mota A
An Bras Dermatol; 2024; 99(3):448-449. PubMed ID: 38378365
[No Abstract] [Full Text] [Related]
11. Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa.
Paller AS; Guide SV; Ayala D; Gonzalez ME; Lucky AW; Bagci IS; Marinkovich MP
J Dermatolog Treat; 2024 Dec; 35(1):2350232. PubMed ID: 38724041
[TBL] [Abstract][Full Text] [Related]
12. Descriptive Study of the Clinical and Molecular Features of Epidermolysis Bullosa Patients in a Romanian European Reference Network-Skin Affiliated Reference Center.
Suru A; Pâslaru AC; Țiplica GS; Sălăvăstru CM
Cureus; 2024 May; 16(5):e61160. PubMed ID: 38803406
[TBL] [Abstract][Full Text] [Related]
13. Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.
Krämer S; Lucas J; Gamboa F; Peñarrocha Diago M; Peñarrocha Oltra D; Guzmán-Letelier M; Paul S; Molina G; Sepúlveda L; Araya I; Soto R; Arriagada C; Lucky AW; Mellerio JE; Cornwall R; Alsayer F; Schilke R; Antal MA; Castrillón F; Paredes C; Serrano MC; Clark V
Spec Care Dentist; 2020 Nov; 40 Suppl 1(Suppl 1):3-81. PubMed ID: 33202040
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity against type VII collagen in inflammatory bowel disease.
Hundorfean G; Neurath MF; Sitaru C
J Cell Mol Med; 2010 Oct; 14(10):2393-403. PubMed ID: 19878366
[TBL] [Abstract][Full Text] [Related]
15. Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa.
Tartaglia G; Fuentes I; Patel N; Varughese A; Israel LE; Park PH; Alexander MH; Poojan S; Cao Q; Solomon B; Padron ZM; Dyer JA; Mellerio JE; McGrath JA; Palisson F; Salas-Alanis J; Han L; South AP
EMBO Mol Med; 2024 Apr; 16(4):870-884. PubMed ID: 38462666
[TBL] [Abstract][Full Text] [Related]
16. Gross motor development in children with epidermolysis bullosa.
Gorrie A; Saad R; Garside L; Bailie C; Wargon O
Child Care Health Dev; 2024 Jan; 50(1):e13194. PubMed ID: 38108617
[TBL] [Abstract][Full Text] [Related]
17. Good clinical response to cemiplimab in a young patient with locally advanced cutaneous squamous cell carcinoma on preexisting recessive dystrophic epidermolysis bullosa.
Ciurescu D; Condruz S; Irimie M
Acta Dermatovenerol Alp Pannonica Adriat; 2024 May; 33(3):actaapa.2024.14. PubMed ID: 38808531
[TBL] [Abstract][Full Text] [Related]
18. Twin prime editing mediated exon skipping/reinsertion for restored collagen VII expression in recessive dystrophic epidermolysis bullosa.
Steinbeck BJ; Gao XD; McElroy AN; Pandey S; Doman JL; Riddle MJ; Xia L; Chen W; Eide CR; Lengert AH; Han SW; Blazar BR; Wandall HH; Dabelsteen S; Liu DR; Tolar J; Osborn MJ
J Invest Dermatol; 2024 May; ():. PubMed ID: 38763174
[TBL] [Abstract][Full Text] [Related]
19. A case of non-hallopeau-siemens recessive dystrophic epidermolysis bullosa.
Kang GS; Ko WT; Kim JH; Choi SM; Kim AS; Kim DH; Suh MK
Ann Dermatol; 2009 Feb; 21(1):49-52. PubMed ID: 20548856
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
